$PSID  news out

DELRAY BEACH, FL, July 10, 2012 – PositiveID Corporation ("PositiveID" or “Company”) (OTCBB: PSID), an emerging growth company and developer of advanced technologies for diabetes management as well as sophisticated airborne bio-threat detection systems for America’s homeland defense, today announced it has entered into an agreement with Simplex Healthcare , Inc. (“Simplex”), the parent company of  the third largest mail order supplier of diabetic testing supplies, Diabetes Care Club, LLC (“DCC”), to provide PositiveID’s iglucose ^® System for diabetes management to people with diabetes. Simplex will purchase iglucose units and will begin trialing the iglucose mobile health diabetes management solution among its members.

PositiveID’s FDA-cleared iglucose uses mobile technology to revolutionize the way individuals with diabetes manage their condition. By wirelessly communicating data from glucometers to the iglucose diabetes management portal, glucose readings can be shared with family members and healthcare professionals. This makes it possible to improve care in a cost-effective manner. iglucose simplifies diabetes management by eliminating the burden of keeping logbooks and empowers individuals with diabetes to be more engaged in the self-management of their condition. iglucose is compatible with leading FDA-cleared glucometers and does not require the use of a cell phone or a wireless plan.